EUVIMEDEUVIMED entdecken
Crossref

Astaxanthin prevents nephrotoxicity through Nrf2/HO-1 pathway

Faezeh Lorestani iD, Ahmad Movahedian iD, Adel Mohammadalipour iD, Mohammad Hashemnia iD, Mohammad Hossein Aarabi iD

Canadian Journal of Physiology and Pharmacology · 2024

DOI: 10.1139/cjpp-2023-0015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Journal of Physiology and Pharmacology, 2024. Verfasst von Faezeh Lorestani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Isfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Acute Kidney Injury. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal toxicity is one of the side effects of methotrexate (MTX). Therefore, this study explored the use of astaxanthin (AST), as a natural carotenoid, against MTX-induced nephrotoxicity emphasizing the changes in oxidative stress and the expression of nuclear factor erythroid 2-related factor 2/heme oxygenase 1 ( Nrf2/HO-1). During the 10 days of the experiment, male Wistar rats in different groups received MTX (10 mg/kg) on days 6, 8, and 10 and three doses of AST (25, 50, and 75 mg/kg) during the entire course. Renal failure caused by MTX was observed in significant histopathological changes and a significant increase in serum levels of creatinine, urea, and uric acid ( p < 0.05). Oxidative change induced by MTX injection was also observed by remarkably increasing the tissue level of malondialdehyde (MDA) and decreasing the activity of superoxide dismutase (SOD) and catalase ( p < 0.001). AST decreases the adverse effects of MTX by upregulating the expression of Nrf2/HO-1 genes ( p < 0.01) and decreasing the tissue level of MDA ( p < 0.01). Also, AST significantly reduced the amount of creatinine, urea, and uric acid in the serum and improved the activity of SOD and catalase in the kidney tissue ( p < 0.05). Thus, AST may protect the kidney against oxidative stress caused by MTX.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2Acute Kidney InjuryRatsAnimalsMaleCatalaseRats, WistarUric AcidCreatinineKidneyMethotrexateOxidative StressSuperoxide DismutaseUreaXanthophylls

Stichwörter der Autor:innen

astaxanthinkidneymethotrexatenephrotoxicityoxidative stress

Substanzen

NF-E2-Related Factor 2CatalaseUric AcidastaxanthineCreatinineMethotrexateSuperoxide DismutaseUreaXanthophylls

Autor:innen und Institutionen

  • Department of Clinical Biochemistry, Isfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Department of Pathobiology, Faculty of Veterinary Medicine, Razi University, Kermanshah, Iran.

ORCID-Profile: Faezeh Lorestani, Ahmad Movahedian, Adel Mohammadalipour, Mohammad Hashemnia, Mohammad Hossein Aarabi

Zitieren

APA

Lorestani, F., Movahedian, A., Mohammadalipour, A., Hashemnia, M., & Aarabi, M. H. (2024). Astaxanthin prevents nephrotoxicity through Nrf2/HO-1 pathway. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2023-0015

Vancouver

Lorestani F, Movahedian A, Mohammadalipour A, Hashemnia M, Aarabi MH. Astaxanthin prevents nephrotoxicity through Nrf2/HO-1 pathway. Canadian Journal of Physiology and Pharmacology. 2024. doi:10.1139/cjpp-2023-0015

BibTeX
@article{Lorestani2024,
  author = {Lorestani, Faezeh and Movahedian, Ahmad and Mohammadalipour, Adel and Hashemnia, Mohammad and Aarabi, Mohammad Hossein},
  title = {Astaxanthin prevents nephrotoxicity through Nrf2/HO-1 pathway},
  journal = {Canadian Journal of Physiology and Pharmacology},
  year = {2024},
  doi = {10.1139/cjpp-2023-0015}
}
Kostenlos starten →